Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
November 12, 2026 1.048
November 11, 2026 1.080
November 10, 2026 1.075
November 09, 2026 1.078
November 06, 2026 1.078
November 05, 2026 1.058
November 04, 2026 1.118
November 03, 2026 1.071
November 02, 2026 1.079
October 30, 2026 1.087
October 29, 2026 1.098
October 28, 2026 1.084
October 27, 2026 1.073
October 26, 2026 1.070
October 23, 2026 1.086
October 22, 2026 1.105
October 21, 2026 1.125
October 20, 2026 1.124
October 19, 2026 1.099
October 16, 2026 1.081
October 15, 2026 1.112
October 14, 2026 1.093
October 13, 2026 1.097
October 12, 2026 1.181
October 09, 2026 1.195
Date Value
October 08, 2026 1.134
October 07, 2026 1.174
October 06, 2026 1.180
October 05, 2026 1.203
October 02, 2026 1.194
October 01, 2026 1.194
September 30, 2026 1.211
September 29, 2026 1.220
September 28, 2026 1.226
September 25, 2026 1.219
September 24, 2026 1.228
September 23, 2026 1.218
September 22, 2026 1.248
September 21, 2026 1.213
September 18, 2026 1.189
September 17, 2026 1.221
September 16, 2026 1.186
September 15, 2026 1.196
September 14, 2026 1.223
September 11, 2026 1.197
September 10, 2026 1.193
September 09, 2026 1.214
September 08, 2026 1.221
September 04, 2026 1.284
September 03, 2026 1.273

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
Moderna, Inc. 13.67
Mereo BioPharma Group Plc 2.054
NuCana Plc 24.80
Immatics NV 1.993

Price to Book Value Related Metrics

PS Ratio 7.607
PEG Ratio -0.0768
Price 85.04
Earnings Yield -8.08%
Market Cap 21.08B
PEGY Ratio -0.0768